Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775383 · ClinicalTrials.gov registry record
The National Myelodysplastic Syndromes (MDS) Study
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 2,115
- Enrollment target
NCT02775383 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 2,115 participants.
The verdict
NCT02775383 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 2,115 participants
- Enrollment target
Study Summary
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
Interventions
- OTHER Therapeutic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,115 participants |
| Start Date | 2016-06-13 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02775383
The ClinicalTrials.gov registry entry for NCT02775383 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapeutic is the first listed.
NCT02775383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02775383 about?
NCT02775383 is a clinical study titled "The National Myelodysplastic Syndromes (MDS) Study". Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical d...
What is the current status of trial NCT02775383?
This trial is currently completed. The enrollment target is 2,115 participants. The study started on 2016-06-13. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT02775383?
The interventions under investigation include: Therapeutic (OTHER).
Who is sponsoring clinical trial NCT02775383?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.